Compare RMD & SLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RMD | SLF |
|---|---|---|
| Founded | 1989 | 1871 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0B | 40.7B |
| IPO Year | 1996 | 2000 |
| Metric | RMD | SLF |
|---|---|---|
| Price | $227.97 | $80.81 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 1 |
| Target Price | ★ $292.56 | $84.00 |
| AVG Volume (30 Days) | ★ 1.2M | 701.5K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | 1.13% | ★ 3.69% |
| EPS Growth | ★ 9.67 | N/A |
| EPS | ★ 10.43 | N/A |
| Revenue | ★ $2,957,013,000.00 | N/A |
| Revenue This Year | $10.60 | N/A |
| Revenue Next Year | $7.41 | $2.68 |
| P/E Ratio | $22.00 | ★ $14.79 |
| Revenue Growth | ★ 13.44 | N/A |
| 52 Week Low | $180.27 | $57.22 |
| 52 Week High | $284.87 | $84.38 |
| Indicator | RMD | SLF |
|---|---|---|
| Relative Strength Index (RSI) | 55.85 | 53.68 |
| Support Level | $199.75 | $77.31 |
| Resistance Level | $233.75 | $81.38 |
| Average True Range (ATR) | 6.12 | 1.14 |
| MACD | -1.73 | 0.15 |
| Stochastic Oscillator | 51.28 | 79.52 |
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
Sun Life Financial is one of the Big Three Canadian life insurers. The Canadian business contributed around 35% of its 2025 adjusted earnings. In that segment, the firm provides health, life insurance, and annuity products to individual and group customers. Its US business is mostly group health and contributed about 17% of the firm's adjusted earnings in 2025. Sun Life also offers life insurance and wealth products in several Asian markets with a strong presence in Hong Kong and the Philippines. The Asia segment contributed around 18% of adjusted 2024 earnings. Its asset management business had around CAD 1.2 trillion total assets under management or administration at the end of 2025 and represents around 30% of the firm's earnings.